[Dissolution determination of new Dihydroartemisinin Tablets]

Area of Science:

• Pharmaceutical Sciences
• Analytical Chemistry
• Drug Development

Background:

• Dihydroartemisinin is a crucial antimalarial drug.
• Existing quality control methods for Dihydroartemisinin Tablets may require updates.
• Dissolution testing is vital for assessing drug bioavailability and efficacy.

Purpose of the Study:

• To develop and validate a new dissolution determination method for Dihydroartemisinin Tablets.
• To establish a reliable analytical technique for quality control.
• To compare the dissolution profiles of new Dihydroartemisinin Tablets against original formulations.

Main Methods:

• Preparation of new Dihydroartemisinin Tablets.
• Dissolution testing using the paddle method in 0.1 mol·L⁻¹ hydrochloric acid.
• High-Performance Liquid Chromatography (HPLC) analysis for dihydroartemisinin quantification.
• Method validation including linearity, precision, and recovery studies.

Main Results:

• A new, validated HPLC method for dihydroartemisinin dissolution was established.
• The method demonstrated high reproducibility, accuracy, and reliability.
• Average dissolutions for new tablets were consistently high (92-94%).
• New Dihydroartemisinin Tablets exhibited superior dissolution rates compared to original tablets.

Conclusions:

• The developed dissolution method is suitable for revising the quality standard of Dihydroartemisinin Tablets.
• The new analytical method provides an objective basis for quality assessment.
• The superior dissolution profile of the new tablets suggests improved therapeutic potential.